Jimmy Doumit, MD
Pulmonary Disease · Bridgeport, WVNPI 1427346410
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,000 of the $4,622 with a category attached, or 64.9%. Intuitive Surgical accounts for 96.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $4,457 and has fallen 97.8% since, to $100 in 2025.
Across 12 payments — averaging $385.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Johnson & Johnson$47
- Pulmonx Corporation$40
- Resmed Corp$31
- Verona Pharma, Inc.$29
- Philips North America LLC$18
What the payments were for
- Travel & lodging$1,44131%
- Food & beverage$1814%
- Education$3,00065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $4,457 |
| Johnson & Johnson(2 entities) | 2 | $47 |
| Pulmonx Corporation | 1 | $40 |
| Resmed Corp | 1 | $31 |
| Verona Pharma, Inc. | 1 | $29 |
| Philips North America LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Da Vinci Surgical System$962
- DA VINCI SP$460
How this compares
$4,622 in reported general payments places this provider in the 75th percentile of 89 pulmonary disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 141 | $153,459 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 12 | $132,349 |
| Spiriva RespimatTiotropium Bromide | 75 | $60,592 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $39,145 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 35 | $25,276 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 40 | $23,896 |
| Incruse ElliptaUmeclidinium Bromide | 31 | $20,919 |
| SymbicortBudesonide/Formoterol Fumarate | 34 | $10,099 |
| DuleraMometasone/Formoterol | 14 | $7,674 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $6,782 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 180 | $6,428 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $4,903 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $4,065 |
| Roflumilast | 24 | $1,171 |
| Azelastine Hcl | 15 | $519 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Bridgeport
- Salam RajjoubBridgeport$29K
- Brandon ShiflettBridgeport$8K
- Melvin SaludesGlen Dale$255K
- Roger AbrahamsMorgantown$133K
- Maria BoustaniBeckley$95K
- Ramzi HaddadinBeckley$43K
- Peter KochupuraMorgantown$22K
- Phillip AguilaMartinsburg$21K
- Ryan WaddellCharleston$13K
- Loay Al AsadiCharleston$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.